Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in SCLX — Scilex Holding Co

CIK 1000275 TORONTO, A6
Back to SCLX Full portfolio

Position in SCLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,611
+$2,983 QoQ
Shares Held
1,745
-31.9% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 72 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,358,401 $5,227,597,337
2 JNJ
Johnson & Johnson
 13,211,475 $3,355,318,297
3 ABBV
AbbVie Inc.
 8,163,806 $2,054,340,133
4 AZN
Astrazeneca PLC
 10,427,503 $1,977,263,112
5 MRK
Merck & Co., Inc.
 14,293,086 $1,836,661,547
6 AMGN
Amgen Inc
 4,328,785 $1,567,539,618
7 PFE
Pfizer Inc
 32,814,260 $790,167,373
8 BMY
Bristol Myers Squibb Co
 12,094,886 $696,907,326

All Filings in SCLX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,611 1,745
2026-03-31 $10,628 1,596
2025-12-31 $10,783 884
2025-09-30 $2,852 145
2025-06-30 $5,399 917
2025-03-31 $3,336 13,400
2024-12-31 $259 608
2024-09-30 $3,146 3,402
2024-06-30 $57 30
2024-03-31 $563 355
2023-12-31 $61 30
2023-09-30 $42 30
2023-06-30 $167 30
2023-03-31 $246 30